APA (7th ed.) Citation

Lechner, C., Saxena, S., Lokhande, H., Breu, M., Eisenkölbl, A., Karenfort, M., . . . Chitnis, T. (2023). A20 (TNFAIP3) Distinguishes Relapse from Remission in Pediatric Patients with Monophasic MOGAD: Preliminary Results. Neuropediatrics, 54, S1. https://doi.org/10.1055/s-0043-1777141

Chicago Style (17th ed.) Citation

Lechner, C., et al. "A20 (TNFAIP3) Distinguishes Relapse from Remission in Pediatric Patients with Monophasic MOGAD: Preliminary Results." Neuropediatrics 54 (2023): S1. https://doi.org/10.1055/s-0043-1777141.

MLA (9th ed.) Citation

Lechner, C., et al. "A20 (TNFAIP3) Distinguishes Relapse from Remission in Pediatric Patients with Monophasic MOGAD: Preliminary Results." Neuropediatrics, vol. 54, 2023, p. S1, https://doi.org/10.1055/s-0043-1777141.